RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,660,022 | +44.7% | 72,411 | +4.1% | 0.00% | – |
| Q2 2023 | $1,147,506 | +188.3% | 69,588 | +212.3% | 0.00% | – |
| Q1 2023 | $398,000 | +69480.4% | 22,285 | +13.5% | 0.00% | – |
| Q4 2022 | $572 | -98.9% | 19,641 | +788.3% | 0.00% | – |
| Q3 2022 | $54,000 | +2600.0% | 2,211 | +401.4% | 0.00% | – |
| Q2 2022 | $2,000 | -99.4% | 441 | -98.4% | 0.00% | – |
| Q1 2022 | $312,000 | +39.9% | 26,981 | +21.1% | 0.00% | – |
| Q4 2021 | $223,000 | -23.9% | 22,280 | -1.0% | 0.00% | – |
| Q3 2021 | $293,000 | -32.5% | 22,501 | +1.5% | 0.00% | – |
| Q2 2021 | $434,000 | -74.5% | 22,169 | -72.2% | 0.00% | – |
| Q1 2021 | $1,699,000 | -35.3% | 79,825 | -9.6% | 0.00% | – |
| Q4 2020 | $2,624,000 | +29.7% | 88,260 | -2.9% | 0.00% | – |
| Q3 2020 | $2,023,000 | -5.3% | 90,854 | -5.2% | 0.00% | – |
| Q2 2020 | $2,137,000 | +35.0% | 95,871 | -7.8% | 0.00% | – |
| Q1 2020 | $1,583,000 | -43.0% | 104,016 | -14.0% | 0.00% | -100.0% |
| Q4 2019 | $2,776,000 | +1.6% | 120,883 | -4.5% | 0.00% | 0.0% |
| Q3 2019 | $2,732,000 | -0.7% | 126,544 | -0.2% | 0.00% | 0.0% |
| Q2 2019 | $2,751,000 | -18.9% | 126,835 | +2.5% | 0.00% | 0.0% |
| Q1 2019 | $3,393,000 | +1.7% | 123,778 | -0.3% | 0.00% | 0.0% |
| Q4 2018 | $3,336,000 | -11.6% | 124,099 | -4.1% | 0.00% | 0.0% |
| Q3 2018 | $3,774,000 | -24.1% | 129,354 | -18.7% | 0.00% | 0.0% |
| Q2 2018 | $4,973,000 | +58.7% | 159,074 | +1.0% | 0.00% | 0.0% |
| Q1 2018 | $3,134,000 | -8.6% | 157,453 | +33.5% | 0.00% | 0.0% |
| Q4 2017 | $3,428,000 | – | 117,977 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |